biliary atresia |
6 |
genes |
6 |
liver fibrosis |
6 |
organoid |
6 |
steroid |
6 |
aflibercept |
1 |
alternate splicing |
1 |
alternative possibility, and cross-species identification - spectral libraries and profiles |
1 |
anti-vascular endothelial growth factor |
1 |
bevacizumab |
1 |
bioinformatics |
1 |
bioinformatics in animal proteomics - methodologies, analyzing protein sets in complex samples |
1 |
biomarker |
1 |
cell transplantation |
1 |
diabetic macular edema |
1 |
difficulties of applying proteomics - and next-generation sequencing, in easing problems |
1 |
dna damage response |
1 |
embryonic stem cells |
1 |
epiblast |
1 |
expressed sequence tag |
1 |
extraembryonic endoderm |
1 |
false discovery rate |
1 |
gata6 |
1 |
genome sequencing, acceleration - new technological developments, "next-generation" sequencers |
1 |
h3k9me3 |
1 |
human |
1 |
human embryo |
1 |
human embryonic stem cells |
1 |
intron-spanning peptides, unique to specific protein - in proteomic analysis of alternative splicing |
1 |
meiotic silencing |
1 |
microrna |
1 |
mouse |
1 |
mouse embryonic stem cells |
1 |
msci |
1 |
peptide identifications |
1 |
peptide spectrum match |
1 |
pluripotency |
1 |
pluripotent stem cell |
1 |
posterior error probability |
1 |
protein identification in proteomics - by ms, in a single stage |
1 |
protein isoforms |
1 |
proteogenomics |
1 |
proteomic analysis, using - one-dimensional gels, 2d gels and multidimensional protein identification technology [mudpit] |
1 |
proteomic data to genome annotation - "proteogenomics" |
1 |
proteomics analysis pipelines and data repositories - as genome annotating proteomics pipeline (gapp) and peptideatlas |
1 |
reprograming |
1 |
retinal pigment epithelium |
1 |
rna-sequencing |
1 |
sex chromosomes |
1 |
tandem ms, single peptide ion - from ms1 stage, fragmented prior to mass analysis in ms2 stage |
1 |
transcriptome |
1 |
transdifferentiation |
1 |
trophectoderm |
1 |
trophoblast stem cells |
1 |